You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Individuals at risk of exposure to SARS-CoV-2

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SARS-CoV-2 Infection Trial in Canada, Sri Lanka (Nitric Oxide, Nasal spray with isotonic saline)

Active, not recruiting
  • SARS-CoV-2 Infection
  • Nitric Oxide
  • Nasal spray with isotonic saline
  • Oshawa, Ontario, Canada
  • +5 more
Nov 3, 2022

COVID-19 Trial in New York (Hydroxychloroquine (HCQ))

Completed
Has Results
  • COVID-19
  • Hydroxychloroquine (HCQ)
  • New York, New York
    NYU Langone Health
Dec 12, 2022

SARS-CoV-2 Infection Trial in Beijing (HH-120 nasal spray 1, HH-120 nasal spray 2, Placebo Comparator 1)

Completed
  • SARS-CoV-2 Infection
  • HH-120 nasal spray 1
  • +3 more
  • Beijing, Beijing, China
    Beijing Ditan Hospital,Capital Medical University
Mar 1, 2023

SARS-CoV-2 Infection Trial in Malaysia, Philippines (Azvudine, Placebo)

Recruiting
  • SARS-CoV-2 Infection
  • Kuala Lumpur, Malaysia
  • +9 more
Jan 5, 2023

COVID-19 Trial in Beijing, Shanghai (HH-120 Nasal Spray, Placebo)

Not yet recruiting
  • COVID-19
  • HH-120 Nasal Spray
  • Placebo
  • Beijing, China
  • +1 more
Mar 27, 2023

COVID-19, SARS-CoV-2 Trial in Moscow, St Petersburg (Biological: AZD3152, Biological: Placebo)

Not yet recruiting
  • COVID-19, SARS-CoV-2
  • Biological: AZD3152
  • Biological: Placebo
  • Moscow, Russian Federation
  • +5 more
Sep 26, 2023

Covid19, SARS-COV-2 Infection Trial (DWJ1248, Placebo)

Terminated
  • Covid19
  • SARS-COV-2 Infection
  • Seoul, Korea, Republic of
    Samsung Medical Center
Dec 4, 2022

LumiraDX SARS-CoV-2 Ag Ultra and LumiraDX SARS-CoV-2 & Flu A/B

Not yet recruiting
  • SARS-CoV-2
  • +4 more
  • LumiraDx SARS-CoV-2 Ag Ultra
  • LumiraDx SARS-CoV-2 & Flu A/B
  • DeLand, Florida
    Hillcrest Medical Research
Feb 6, 2023

COVID-19 Trial in Shanghai (Azvudine, Placebo)

Recruiting
  • COVID-19
  • Shanghai, Shanghai, China
    Huashan Hospital
Jan 28, 2023

Ventilatory and Perfusion Abnormalities in Individuals With

Recruiting
  • Post-Acute COVID-19
  • +3 more
  • Computed Tomography of the Chest
  • Boston, Massachusetts
    Tufts Medical Center
May 18, 2023

Japan After Severe Acute Respiratory Syndrome Coronavirus 2

Not yet recruiting
  • SARS-CoV-2
    • Tokyo, Japan
      CMIC Co., Ltd
    Jun 6, 2023

    COVID-19, SARS-CoV-2 Trial in United States (VYD222, Normal saline)

    Recruiting
    • COVID-19
    • SARS-CoV-2
    • Culver City, California
    • +15 more
    Sep 8, 2023

    Patients and Healthcare Workers in a Hospital Department

    Completed
    • COVID-19
    • COVID-19 test, polymerase chain reaction for SARS-CoV-2
    • Copenhagen, Denmark
      Rigshospitalet University Hospital of Copenhagen
    Jan 31, 2023

    Japan of Shock and Anaphylaxis After Severe Acute Respiratory

    Active, not recruiting
    • SARS-CoV-2
      • Tokyo, Japan
        CMIC Co., Ltd.
      Jun 5, 2023

      COVID-19, SARS-CoV-2 Infection Trial in Beijing (HH-120 Nasal Spray)

      Completed
      • COVID-19
      • SARS-CoV-2 Infection
      • HH-120 Nasal Spray
      • Beijing, Beijing, China
        Beijing Ditan Hospital,Capital Medical University
      Feb 26, 2023

      COPD, Bronchiectasis Trial in Manchester, Newcastle Upon Tyne (RESP301)

      Suspended
      • COPD
      • Bronchiectasis
      • Manchester, United Kingdom
      • +1 more
      Dec 12, 2022

      Severe Exacerbation of Severe Acute Respiratory Syndrome

      Active, not recruiting
      • SARS-CoV-2
        • Tokyo, Japan
          CMIC Co. Ltd.,
        Jun 5, 2023

        End-stage Renal Disease, SARS-CoV-2 Acute Respiratory Disease, Dialysis; Complications Trial (Offering SARS-CoV-2 test)

        Not yet recruiting
        • End-stage Renal Disease
        • +2 more
        • Offering SARS-CoV-2 test
        • (no location specified)
        Dec 12, 2022

        COVID-19 Respiratory Infection, SARS-CoV-2 Acute Respiratory Disease Trial in Pamplona (Nasal Photodisinfection, Sham

        Completed
        • COVID-19 Respiratory Infection
        • SARS-CoV-2 Acute Respiratory Disease
        • Nasal Photodisinfection
        • Sham Comparator: Control
        • Pamplona, Spain
          Clinica Universidad de Navarra
        Aug 10, 2022

        In Utero Exposure to SARS-CoV-2 and Cardiovascular and Metabolic

        Enrolling by invitation
        • In Utero SARS-CoV-2 Exposure
          • Boston, Massachusetts
            Massachusetts General Hospital
          Jul 18, 2022

          SaRS-Cov-2 Antibodies Following Exposure to Coronavirus Disease

          Completed
          • COVID-19 Infection
          • SARS-CoV-2 antibodies
          • Vandoeuvre les Nancy, US And Canada Only, France
            CHRU de Nancy, Université de Lorraine
          Jul 18, 2022

          Covid19, Covid19 Drug Treatment, Severe Acute Respiratory Syndrome Coronavirus 2 Trial in Bobo-Dioulasso, Conakry (Nitazoxanide

          Recruiting
          • Covid19
          • +3 more
          • Nitazoxanide and Ciclésonide
          • +3 more
          • Bobo-Dioulasso, Burkina Faso
          • +1 more
          Jan 30, 2023

          Health Behavior Trial (Connect2Test Intervention)

          Completed
          • Health Behavior
          • Connect2Test Intervention
          • Eugene, Oregon
            University of Oregon
          Oct 12, 2022

          Covid19, SARS-CoV Infection Trial in Johannesburg (Nitazoxanide, Sofosbuvir/Daclatasvir)

          Completed
          • Covid19
          • SARS-CoV Infection
          • Johannesburg, Gauteng, South Africa
          • +1 more
          Jun 6, 2022

          COVID-19 Infection, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Seattle (Questionnaire Administration,

          Suspended
          • COVID-19 Infection
          • +2 more
          • Questionnaire Administration
          • Sotrovimab
          • Seattle, Washington
            Fred Hutch/University of Washington Cancer Consortium
          Jan 24, 2023